Living donor liver transplantation in polycystic liver disease

15Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

In the current Model for End-Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved. Traditionally, a caval resection has been advocated in these patients because of the difficulty of the hepatectomy with hepatomegaly, which makes living donation impossible. This series looks at 3 patients who underwent a caval sparing hepatectomy and subsequent living donor liver transplantation (LDLT) for PCLD. Graft and patient survival was 100%, and there were few complications in either donors or recipients. LDLT is an ideal option for patients with PCLD and preserved liver function but poor quality of life. © 2008 AASLD.

Cite

CITATION STYLE

APA

Mekeel, K. L., Moss, A. A., Reddy, K. S., Douglas, D. D., Vargas, H. E., Carey, E. J., … Mulligan, D. C. (2008). Living donor liver transplantation in polycystic liver disease. Liver Transplantation, 14(5), 680–683. https://doi.org/10.1002/lt.21423

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free